Group 1: Equity Transfer of Guangdong Yihua Real Estate Development Co., Ltd. - Company plans to publicly transfer 41% equity stake in Guangdong Yihua Real Estate Development Co., Ltd. at a minimum price of 1 yuan due to asset structure optimization [1][3] - The investment in Yihua has been impaired to a book value of 0, leading to the decision to transfer the stake [3] - The transaction has been approved by the board and will require shareholder approval before proceeding with the public listing [3] Group 2: Sale of Stock Assets - Company intends to sell stock assets including shares of Yibai Pharmaceutical and others, expecting proceeds to exceed 50% of last year's net profit [4][5] - The sale includes 8,685,953 shares of Yibai Pharmaceutical, 970,605 shares of Aoride, and others, with a minimum expected revenue of 46,948,724.69 yuan [5] - The sale will occur between shareholder approval and December 31, 2025, using market-based pricing strategies [5] Group 3: Debt Asset Transfer to Controlling Shareholder - Company plans to transfer debt assets to its controlling shareholder's subsidiary for a price of 334 million yuan, constituting a related party transaction [6] - The transfer aligns with the company's strategic shift towards urban operation services and away from real estate development [6] - The market value of the debt asset is assessed at 334 million yuan, and the transfer price complies with legal regulations [6] Group 4: Market Performance - As of September 11, the company's stock price increased by 2.74% to 5.99 yuan per share, with a market capitalization of 5.112 billion yuan [7][8] - The trading volume reached 331 million yuan with a turnover rate of 6.52% [8]
“1元”甩卖!珠江股份拟挂牌转让旗下房地产公司41%股权